Valneva revives Scottish vaccine manufacturing plans
Valneva has been awarded up to £20m ($27m) in R&D funding from Scottish Enterprise: which will be used to revive its plans to increase vaccine manufacturing in Scotland.
Archives for February 22, 2022
Moderna initiates Phase 3 trial for RSV vaccine candidate
Moderna has initiated the Phase 3 portion of its pivotal respiratory syncytial virus (RSV) vaccine trial: looking towards its ultimate goal to combine the vaccine with its COVID-19 and flu boosters into a single dose booster.
BioNTech and Medigene team up on T cell immunotherapy
mRNA innovator, BioNTech, inked a new deal this week, with the intention of extending its oncology footprint.
4D Pharma to trial LBPs in patients with Parkinson’s disease: ‘We are continuing to expand clinical pathways for the microbiome field’
4D Pharma says the US Food and Drug Administration (FDA) has cleared its IND application for the first in-human trial to use Live Biotherapeutics (LBPs) for the treatment of Parkinson’s disease.